This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Darryl Neil Penenberg, PhD. Is Recognized By Continental Who's Who As A Pinnacle Professional In The Pharmaceutical Industry

NEW YORK, June 20, 2013 /PRNewswire/ -- /Continental Who's Who/ -- Darryl Neil Penenberg, PhD. is recognized by Continental Who's Who as a Pinnacle Professional in the Pharmaceutical Industry as a result of his role as President of DNP Consultants, a company specializing in design and analysis of clinical trials data used for the development of new drugs and vaccines, clinical program development, protocol design, statistical trouble-shooting, and report/dossier preparation/review for regulatory submission. 

Dr. Penenberg is a Biostatistician and Global Regulatory Affairs Professional with more than 26 years of experience in clinical trial analyses and regulatory submission auditing in the Pharmaceuticals industry. After establishing DNP Consultants in 2012, he focused his practice on clinical trials for pain, epilepsy, post-operative gastro intestinal surgery, advanced medical illness, HIV and AIDS, oncology, cardiovascular disease, as well as psychiatric and orthopedic clinical trials. As President of DNP, Dr. Penenberg oversees all daily operations of the consultancy, including managing the activities of the firm's Biostatistician, finance management, marketing, and meeting with clients.

Throughout his illustrious career, Dr. Penenberg has worked on phase one through four clinical trials leading to Regulatory approvals. He has expertise in experimental design, power calculations, survival analyses, categorical data analyses, de-identification of data sources, big data sampling problems and Quality of Life analyses. In addition, he has worked on the preparation of clinical study reports for Regulatory submissions, meeting abstract and journal publications as well as performing exploratory analyses for promotional response marketing modeling used for materials for sales representatives.

His mathematical interests are Algebraic Number Theory, Algebraic Geometry and Elliptic Curves and Modular Forms.

As a result of his professionalism and dedication to the Pharmaceutical Industry, Dr. Penenberg maintains affiliations with several prestigious organizations. He is an honored Fellow of the Royal Statistical Society and an Associate Member of Sigma Xi. Additionally, he is a member of the New York Biotechnology Association, New York Academy of Sciences; Stevens Alumni Association; The Society for Mathematical Biology; Biometrics Society; Institute of Mathematical Statistics; American Statistical Association; Bernoulli Society; International Statistical Institute; American Mathematical Society; Mathematical Association of America; as well as The Society of Rheology through the American Institute of Physics.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs